Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$5.5M
1M shares
52-week range
$3.08 – $102.00
5% from low
Exchange
NASDAQ
CS
Borrow rate
213.41%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $905.0K | $5.6M | $333.6M |
| Cost of revenue | $0 | $0 | $1.0M | $5.2M | $219.6M |
| Gross profit | $0 | $0 | −$143.3K | $472.6K | $114.0M |
| Gross margin | — | — | -15.8% | 8.4% | 34.2% |
| R&D | $0 | $985.2K | $1.3M | $1.8M | $9.2M |
| Operating income | −$13.8K | −$1.7M | −$6.7M | −$9.0M | −$10.5M |
| EBITDA | −$13.8K | −$3.7M | −$51.7M | −$6.2M | −$69.0M |
| Net income | −$13.8K | −$4.5M | −$51.8M | −$7.3M | −$111.5M |
| Net margin | — | — | -5722.2% | -130.0% | -33.4% |
| EPS (diluted) | -0.01 | -1.80 | -22.50 | -2.85 | -258.75 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $9M | $-36.00 | $-36.00–$-36.00 | 1 |
| 2027 | $77M | $6.00 | $6.00–$6.00 | 1 |
| 2028 | $131M | $30.00 | $30.00–$30.00 | 1 |
Forward consensus · source: Financial Modeling Prep
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
www.moolecscience.comNo one on the platform currently holds MLEC.
No tracked institution reports a position in MLEC as of their last filing.
| Execution date | Ratio |
|---|---|
| 2026-01-05 | 1-for-15reverse |
| 2025-05-14 | 1-for-10reverse |
No one on the platform has traded MLEC yet.
| $5M |
| — |
| NCELNewcelX Ltd. | $3.69 | +1.37% | $2M | — |
| NKGNNKGen Biotech, Inc. Common Stock | $0.06 | +0.00% | $8M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$LABT Shes ready to blow like $QH $UPC $MLEC low float theme HOT
View on StockTwits ↗$MLEC Another banner day with 8.8 thousand shares traded and $1.4 spread. POS
View on StockTwits ↗$MLEC In early 2026, the company achieved a critical milestone when the US Department of Agriculture (USDA) cleared its genetically modified soybean products, ruling them safe and not subject to restrictive regulatory overhauls. Moolec recently announced positive commercial milestones regarding its soybean crushing processes. The astronomical borrow rate (over 222%) makes shorting this micro-float too expensive and highly dangerous due to rapid retail-driven momentum spikes. NFA
View on StockTwits ↗$MLEC been waiting for a few weeks lol let’s go!!
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.